Nam HS - Search Results

1

Lung Cancer Risk and Residential Exposure to Air Pollution: A Korean Population-Based Case-Control Study.

Lamichhane DK, Kim HC, Choi CM, Shin MH, Shim YM, Leem JH, Ryu JS, Nam HS, Park SM. Lamichhane DK, et al. Among authors: nam hs. Yonsei Med J. 2017 Nov;58(6):1111-1118. doi: 10.3349/ymj.2017.58.6.1111. Yonsei Med J. 2017. PMID: 29047234 Free PMC article.

2

Gender differences in susceptibility to smoking among patients with lung cancer.

Ryu JS, Jeon SH, Kim JS, Lee JH, Kim SH, Hong JT, Jeong JH, Jeong JJ, Lee MD, Min SJ, Nam HS, Cho JH, Kwak SM, Lee HL, Kim HJ. Ryu JS, et al. Among authors: nam hs. Korean J Intern Med. 2011 Dec;26(4):427-31. doi: 10.3904/kjim.2011.26.4.427. Epub 2011 Nov 28. Korean J Intern Med. 2011. PMID: 22205843 Free PMC article.

3

Overexpression of a novel regulator of p120 catenin, NLBP, promotes lung adenocarcinoma proliferation.

Kim CH, Nam HS, Lee EH, Han SH, Cho HJ, Chung HJ, Lee NS, Choi SJ, Kim H, Ryu JS, Kwon J, Kim H. Kim CH, et al. Among authors: nam hs. Cell Cycle. 2013 Aug 1;12(15):2443-53. doi: 10.4161/cc.25451. Epub 2013 Jun 28. Cell Cycle. 2013. PMID: 23839039 Free PMC article.

4

Indoor Radon and Lung Cancer: National Radon Action Plans Are Urgently Required.

Nam HS, Ryu JS. Nam HS, et al. Yonsei Med J. 2018 Nov;59(9):1013-1014. doi: 10.3349/ymj.2018.59.9.1013. Yonsei Med J. 2018. PMID: 30328314 Free PMC article. No abstract available.

5

The soluble tumor necrosis factor-alpha receptor suppresses airway inflammation in a murine model of acute asthma.

Nam HS, Lee SY, Kim SJ, Kim JS, Kwon SS, Kim YK, Kim KH, Moon HS, Song JS, Park SH, Kim SC. Nam HS, et al. Yonsei Med J. 2009 Aug 31;50(4):569-75. doi: 10.3349/ymj.2009.50.4.569. Epub 2009 Aug 19. Yonsei Med J. 2009. PMID: 19718408 Free PMC article.

6

Prognostic effect of age on survival of patients with stage I adenocarcinoma of the lung.

Ryu JS, Choi CM, Yang SC, Song SY, Jeon YJ, Jang TW, Kim DJ, Jang SH, Yang SH, Lee MK, Lee KH, Jo HJ, Jang SJ, Kim YT, Cho JH, Choi YD, Nam HS, Kim HJ, Suh YJ. Ryu JS, et al. Among authors: nam hs. Tumori. 2012 Jan-Feb;98(1):99-104. doi: 10.1177/030089161209800114. Tumori. 2012. PMID: 22495709

7

Dramatic response of acute disseminated intravascular coagulation to erlotinib in a patient with lung adenocarcinoma with activating EGFR mutation.

Kim JS, Ryu JS, Jeon SH, Kim HJ, Nam HS, Cho JH, Kwak SM, Lee HL. Kim JS, et al. Among authors: nam hs. J Int Med Res. 2018 Jan;46(1):533-537. doi: 10.1177/0300060517720099. Epub 2017 Jul 21. J Int Med Res. 2018. PMID: 28730909 Free PMC article.

8

Differential effect of polymorphisms of CMPK1 and RRM1 on survival in advanced non-small cell lung cancer patients treated with gemcitabine or taxane/cisplatinum.

Ryu JS, Shin ES, Nam HS, Yi HG, Cho JH, Kim CS, Kim HJ, Lee JE. Ryu JS, et al. Among authors: nam hs. J Thorac Oncol. 2011 Aug;6(8):1320-9. doi: 10.1097/JTO.0b013e3182208e26. J Thorac Oncol. 2011. PMID: 21642870 Free article.

9

Lack of association of genetic variations of deoxycytidine kinase with toxicity or survival of non-small-cell lung cancer patients treated with gemcitabine plus cisplatin.

Ryu JS, Kim HJ, Shin ES, Nam HS, Cho JH, Lee JE. Ryu JS, et al. Among authors: nam hs. Oncol Res. 2012;20(1):25-30. doi: 10.3727/096504012x13425470196137. Oncol Res. 2012. PMID: 23035362

10

Multiple hypercoagulability disorders at presentation of non-small-cell lung cancer.

Lee JM, Lim JH, Kim JS, Park JS, Memon A, Lee SK, Nam HS, Cho JH, Kwak SM, Lee HL, Kim HJ, Hong GJ, Ryu JS. Lee JM, et al. Among authors: nam hs. Tuberc Respir Dis (Seoul). 2014 Jul;77(1):34-7. doi: 10.4046/trd.2014.77.1.34. Epub 2014 Jul 31. Tuberc Respir Dis (Seoul). 2014. PMID: 25114702 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

721 results

Search Page